Future of drugs-Diabetes_LIK-066
Drug Name
|
(S)-Pyrrolidine-2-carboxylic acid
compound with
(2S,3R,4R,5S,6R)-2-(3-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-4-ethylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
(2:1)
|
Structure
|
|
Drug
Code
|
LIK-066
|
Synonym
|
-
|
Molecular
Formula
|
C23H28O7.2
C6 H11NO
|
Innovator
|
Novartis
|
Condition
|
Type-2
diabetes mellitus
|
Mechanism
of Action
|
Sodium-glucose
transporter 2 inhibitor
|
Clinical
Phase
|
II in USA
|
Comments
Post a Comment